InnovAge Holding Corp. (OTCMKTS:INNV - Get Free Report) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $5.84 and traded as low as $4.87. InnovAge shares last traded at $4.97, with a volume of 35,819 shares changing hands.
InnovAge Trading Down 5.5 %
The company has a market cap of $673.21 million, a P/E ratio of -41.42 and a beta of 0.39. The firm's 50 day moving average is $5.84 and its two-hundred day moving average is $5.47. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.25.
InnovAge (OTCMKTS:INNV - Get Free Report) last posted its earnings results on Tuesday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.01. The firm had revenue of $199.40 million during the quarter, compared to analyst estimates of $190.19 million. InnovAge had a negative net margin of 6.17% and a negative return on equity of 13.04%. As a group, equities research analysts anticipate that InnovAge Holding Corp. will post -0.25 EPS for the current year.
InnovAge Company Profile
(
Get Free Report)
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Further Reading
Before you consider InnovAge, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InnovAge wasn't on the list.
While InnovAge currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
